Noxafil Package insert

(Posaconazole)

  • Extended release
  • Liquid
  • Aspergillosis
  • Invasive
  • In severely immunocompromised patients; Prophylaxis Disseminated candidiasis
  • Severely immunocompromised patients; Prophylaxis HIV infection - Oropharyngeal candidiasis Oropharyngeal candidiasis
Back to: Full Site Navigation

FDA package inserts for Noxafil (Posaconazole)

This is the FDA package insert, supplied by pharmaceutical companies

Downloading FDA Package Insert for Noxafil DR tablet, suspension